| Synaptic NMDA receptor activity boosts intrinsic antioxidant defenses S Papadia, FX Soriano, F Léveillé, MA Martel, KA Dakin, HH Hansen, ... Nature neuroscience 11 (4), 476-487, 2008 | 606 | 2008 |
| N-Acylethanolamines and precursor phospholipids—relation to cell injury HS Hansen, B Moesgaard, HH Hansen, G Petersen Chemistry and physics of lipids 108 (1-2), 135-150, 2000 | 272 | 2000 |
| Cognitive improvement by activation of α7 nicotinic acetylcholine receptors: from animal models to human pathophysiology MS Thomsen, HH Hansen, MB Timmerman, JD Mikkelsen Current pharmaceutical design 16 (3), 323-343, 2010 | 270 | 2010 |
| Mouse models of nonalcoholic steatohepatitis in preclinical drug development HH Hansen, M Feigh, SS Veidal, KT Rigbolt, N Vrang, K Fosgerau Drug discovery today 22 (11), 1707-1718, 2017 | 256 | 2017 |
| Anandamide, but not 2‐arachidonoylglycerol, accumulates during in vivo neurodegeneration HH Hansen, PC Schmid, P Bittigau, I Lastres‐Becker, F Berrendero, ... Journal of neurochemistry 78 (6), 1415-1427, 2001 | 255 | 2001 |
| Mechanisms leading to disseminated apoptosis following NMDA receptor blockade in the developing rat brain HH Hansen, T Briem, M Dzietko, M Sifringer, A Voss, W Rzeski, ... Neurobiology of disease 16 (2), 440-453, 2004 | 210 | 2004 |
| Hepatic transcriptome signatures in patients with varying degrees of nonalcoholic fatty liver disease compared with healthy normal-weight individuals MP Suppli, KTG Rigbolt, SS Veidal, S Heebøll, PL Eriksen, M Demant, ... American Journal of Physiology-Gastrointestinal and Liver Physiology 316 (4 …, 2019 | 184 | 2019 |
| Erythropoietin protects the developing brain against N-methyl-D-aspartate receptor antagonist neurotoxicity M Dzietko, U Felderhoff-Mueser, M Sifringer, B Krutz, P Bittigau, F Thor, ... Neurobiology of disease 15 (2), 177-187, 2004 | 180 | 2004 |
| NMDA antagonist inhibits the extracellular signal-regulated kinase pathway and suppresses cancer growth A Stepulak, M Sifringer, W Rzeski, S Endesfelder, A Gratopp, EE Pohl, ... Proceedings of the National Academy of Sciences 102 (43), 15605-15610, 2005 | 175 | 2005 |
| The GLP-1 receptor agonist liraglutide improves memory function and increases hippocampal CA1 neuronal numbers in a senescence-accelerated mouse model of Alzheimer’s disease HH Hansen, K Fabricius, P Barkholt, ML Niehoff, JE Morley, J Jelsing, ... Journal of Alzheimer's Disease 46 (4), 877-888, 2015 | 165 | 2015 |
| Neonatal administration of the selective serotonin reuptake inhibitor Lu 10–134-C increases forced swimming-induced immobility in adult rats: a putative animal model of depression? HH Hansen, C Sanchez, E Meier Journal of Pharmacology and Experimental Therapeutics 283 (3), 1333-1341, 1997 | 150 | 1997 |
| Alleviation of motor hyperactivity and neurochemical deficits by endocannabinoid uptake inhibition in a rat model of Huntington's disease I Lastres‐Becker, HH Hansen, F Berrendero, R De Miguel, ... Synapse 44 (1), 23-35, 2002 | 136 | 2002 |
| Metabolic and hepatic effects of liraglutide, obeticholic acid and elafibranor in diet-induced obese mouse models of biopsy-confirmed nonalcoholic steatohepatitis KS Tølbøl, MNB Kristiansen, HH Hansen, SS Veidal, KTG Rigbolt, ... World journal of gastroenterology 24 (2), 179, 2018 | 122 | 2018 |
| Accumulation of the anandamide precursor and other N‐acylethanolamine phospholipids in infant rat models of in vivo necrotic and apoptotic neuronal death HH Hansen, C Ikonomidou, P Bittigau, SH Hansen, HS Hansen Journal of neurochemistry 76 (1), 39-46, 2001 | 118 | 2001 |
| Formation of N-acyl-phosphatidylethanolamines and N-acylethanolamines: Proposed role in neurotoxicity HS Hansen, L Lauritzen, B Moesgaard, AM Strand, HH Hansen Biochemical pharmacology 55 (6), 719-725, 1998 | 115 | 1998 |
| Blockade of cannabinoid CB1 receptor function protects against in vivo disseminating brain damage following NMDA‐induced excitotoxicity HH Hansen, I Azcoitia, S Pons, J Romero, LM García‐Segura, JA Ramos, ... Journal of neurochemistry 82 (1), 154-158, 2002 | 103 | 2002 |
| Kv7 channels: interaction with dopaminergic and serotonergic neurotransmission in the CNS HH Hansen, O Waroux, V Seutin, TJ Jentsch, S Aznar, JD Mikkelsen The Journal of physiology 586 (7), 1823-1832, 2008 | 100 | 2008 |
| Towards a standard diet-induced and biopsy-confirmed mouse model of non-alcoholic steatohepatitis: Impact of dietary fat source ML Boland, D Oró, KS Tølbøl, ST Thrane, JC Nielsen, TS Cohen, ... World journal of gastroenterology 25 (33), 4904, 2019 | 96 | 2019 |
| Cannabinoids enhance susceptibility of immature brain to ethanol neurotoxicity HH Hansen, B Krutz, M Sifringer, V Stefovska, P Bittigau, F Pragst, ... Annals of Neurology: Official Journal of the American Neurological …, 2008 | 91 | 2008 |
| The KCNQ channel opener retigabine inhibits the activity of mesencephalic dopaminergic systems of the rat HH Hansen, C Ebbesen, C Mathiesen, P Weikop, LC Rønn, O Waroux, ... Journal of Pharmacology and Experimental Therapeutics 318 (3), 1006-1019, 2006 | 89 | 2006 |
Jens D MikkelsenProfessor of Translational Neuropharmacology and CSO在 dadlnet.dk 的电子邮件经过验证
